Research > ETFs > ETF / ETP Commentary > 

A New King of Dividend ETFs

The Schwab U.S. Dividend Equity ETF (SCHD) is now the largest dividend ETF in the U.S. As of mid-November 2026, the fund held $125 billion in assets under management. It combines rigorous fundamental screening with a low 0.06% expense ratio. The 15-year old SCHD has gathered an impressive $28 billion of new money in 2026.Key Takeaways Category Leadership at $125 Billion: The Schwab U.S. Dividend Equity ETF (SCHD) is now the largest U.S. dividend ETF, pairing a 0.06% expense ratio with strict fundamental screens. Methodology Drives Outperformance: SCHD is up 34% this year versus 15% for the Vanguard Dividend Appreciation ETF (VIG A-). This highlights how index construction shapes returns across dividend growth funds. Resilience in a Higher-Rate World: SCHD screens for strong cash flow relative to debt, which isolates durable blue-chip leaders like Chevron, Procter & Gamble, and Texas Instruments. Index-based dividend ETFs generally fall into two broad categories: dividend growth and high dividend yield. However, not all dividend growth ETFs or high-yield ETFs are constructed the same, leading to wide performance dispersion. Within the dividend growth camp, SCHD is up 34% this year compared to 15% for the $118 billion Vanguard Dividend Appreciation ETF (VIG). While VIG emphasizes a long streak of annual dividend increases, SCHD also pairs dividend growth with profitability and yield screens. SCHD became the new king of dividend ETFs in November, as it has been more popular than VIG. The Vanguard ETF added just $1.2 billion this year. Similarly, high-dividend yield funds differ sharply in how holdings are weighted. For example, there are market-cap-weighted ETFs like the Vanguard High Dividend Yield Index ETF (VYM A) and the equal-weighted, sector-neutral ALPS Sector Dividend Dogs ETF (SDOG B-).Inside SCHD’s Quality-Screened PortfolioSCHD holds 100 U.S. companies that have paid dividends for at least 10 straight years. Stocks are further screened on four metrics: cash flow to total debt, return on equity, indicated dividend yield, and five-year dividend growth rate. SCHD’s top holdings as of November 16, 2026 feature cash-rich leaders across consumer, healthcare, energy, and technology sectors: Consumer Stocks: Procter & Gamble (PG), Coca-Cola (KO), PepsiCo (PEP), and Home Depot (HD). Healthcare: Amgen (AMGN) and UnitedHealth Group (UNH). Energy: Chevron (CVX) and ConocoPhillips (COP). Technology: Texas Instruments (TXN) and Qualcomm (QCOM).Why Dividend Growth Wins in a Higher-Rate WorldDavid Botset, managing director and head of strategy, innovation and stewardship at Schwab Asset Management, highlighted the fund’s appeal. He noted that investors value SCHD’s low costs, tax efficiency, and steady distributions. Botset added that in a higher-interest-rate environment, heavily indebted companies face steep refinancing costs that can threaten dividends. By filtering for strong cash flow relative to debt, SCHD isolates durable businesses capable of growing their payouts despite rate pressures. VettaFi LLC (“VettaFi”) is the index provider for SDOG, for which it receives an index licensing fee. However, SDOGis not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of SDOG. For more news, information, and analysis, visit the Equity ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.